Delayed
Japan Exchange
07:00:00 02/05/2024 BST
|
5-day change
|
1st Jan Change
|
6,382
JPY
|
-2.73%
|
|
+0.66%
|
+20.67%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
2,647,912
|
2,396,050
|
2,261,269
|
2,336,038
|
2,870,266
|
3,462,491
|
-
|
-
|
Enterprise Value (EV)
1 |
2,500,398
|
2,220,358
|
1,986,216
|
2,058,563
|
2,495,550
|
2,966,118
|
2,827,541
|
2,687,549
|
P/E ratio
|
20.8
x
|
16.2
x
|
18
x
|
17.4
x
|
23.6
x
|
13.5
x
|
14.5
x
|
16.6
x
|
Yield
|
2.05%
|
2.26%
|
2.4%
|
2.32%
|
2.08%
|
1.89%
|
1.95%
|
2.05%
|
Capitalization / Revenue
|
1.9
x
|
1.68
x
|
1.51
x
|
1.34
x
|
1.42
x
|
1.6
x
|
1.61
x
|
1.62
x
|
EV / Revenue
|
1.79
x
|
1.56
x
|
1.33
x
|
1.18
x
|
1.24
x
|
1.37
x
|
1.31
x
|
1.26
x
|
EV / EBITDA
|
9.91
x
|
7.99
x
|
8.3
x
|
8.43
x
|
10.5
x
|
6.56
x
|
6.62
x
|
6.98
x
|
EV / FCF
|
23.7
x
|
20.2
x
|
16.9
x
|
15.8
x
|
34.5
x
|
8.6
x
|
12.4
x
|
13.1
x
|
FCF Yield
|
4.22%
|
4.96%
|
5.91%
|
6.33%
|
2.89%
|
11.6%
|
8.06%
|
7.62%
|
Price to Book
|
1.5
x
|
1.29
x
|
1.12
x
|
1.05
x
|
1.2
x
|
1.34
x
|
1.26
x
|
1.2
x
|
Nbr of stocks (in thousands)
|
542,272
|
542,338
|
542,401
|
542,634
|
542,686
|
542,540
|
-
|
-
|
Reference price
2 |
4,883
|
4,418
|
4,169
|
4,305
|
5,289
|
6,382
|
6,382
|
6,382
|
Announcement Date
|
14/02/20
|
12/02/21
|
10/02/22
|
14/02/23
|
14/02/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
1,396,200
|
1,422,826
|
1,498,276
|
1,737,998
|
2,018,568
|
2,168,206
|
2,152,743
|
2,138,695
|
EBITDA
1 |
252,275
|
278,005
|
239,352
|
244,084
|
237,389
|
452,223
|
427,117
|
384,774
|
EBIT
1 |
176,600
|
198,582
|
154,497
|
150,323
|
139,612
|
342,084
|
313,624
|
273,609
|
Operating Margin
|
12.65%
|
13.96%
|
10.31%
|
8.65%
|
6.92%
|
15.78%
|
14.57%
|
12.79%
|
Earnings before Tax (EBT)
1 |
173,515
|
189,988
|
163,638
|
172,954
|
142,655
|
336,304
|
320,582
|
277,832
|
Net income
1 |
127,200
|
148,137
|
125,463
|
134,019
|
121,616
|
254,478
|
233,233
|
204,651
|
Net margin
|
9.11%
|
10.41%
|
8.37%
|
7.71%
|
6.02%
|
11.74%
|
10.83%
|
9.57%
|
EPS
2 |
234.6
|
273.2
|
231.3
|
247.0
|
224.1
|
472.2
|
439.8
|
383.3
|
Free Cash Flow
1 |
105,501
|
110,042
|
117,409
|
130,273
|
72,244
|
345,000
|
228,003
|
204,825
|
FCF margin
|
7.56%
|
7.73%
|
7.84%
|
7.5%
|
3.58%
|
15.91%
|
10.59%
|
9.58%
|
FCF Conversion (EBITDA)
|
41.82%
|
39.58%
|
49.05%
|
53.37%
|
30.43%
|
76.29%
|
53.38%
|
53.23%
|
FCF Conversion (Net income)
|
82.94%
|
74.28%
|
93.58%
|
97.2%
|
59.4%
|
135.57%
|
97.76%
|
100.08%
|
Dividend per Share
2 |
100.0
|
100.0
|
100.0
|
100.0
|
110.0
|
120.4
|
124.6
|
130.8
|
Announcement Date
|
14/02/20
|
12/02/21
|
10/02/22
|
14/02/23
|
14/02/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019 S2
|
2020 S1
|
2021 S1
|
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 S1
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 S1
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 S1
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Net sales
1 |
725,069
|
695,443
|
718,815
|
388,602
|
390,859
|
380,308
|
433,999
|
814,307
|
451,812
|
471,879
|
448,344
|
499,193
|
947,537
|
531,543
|
539,488
|
519,517
|
536,229
|
985,594
|
570,922
|
564,696
|
-
|
EBITDA
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-35,534
|
118,085
|
134,033
|
-
|
113,043
|
92,055
|
-
|
EBIT
1 |
80,076
|
118,008
|
111,169
|
46,961
|
7,278
|
20,749
|
46,397
|
67,146
|
58,548
|
35,475
|
76,779
|
53,911
|
130,690
|
71,960
|
-63,038
|
92,021
|
93,681
|
151,026
|
94,575
|
65,732
|
-
|
Operating Margin
|
11.04%
|
16.97%
|
15.47%
|
12.08%
|
1.86%
|
5.46%
|
10.69%
|
8.25%
|
12.96%
|
7.52%
|
17.13%
|
10.8%
|
13.79%
|
13.54%
|
-11.68%
|
17.71%
|
17.47%
|
15.32%
|
16.57%
|
11.64%
|
-
|
Earnings before Tax (EBT)
1 |
80,094
|
113,876
|
119,207
|
47,101
|
-2,670
|
30,985
|
61,803
|
92,788
|
53,211
|
26,955
|
79,242
|
59,591
|
138,833
|
74,375
|
-70,553
|
100,079
|
93,343
|
151,026
|
89,821
|
78,674
|
-
|
Net income
1 |
59,437
|
86,810
|
91,407
|
35,241
|
-1,185
|
23,255
|
46,498
|
69,753
|
41,277
|
22,989
|
61,430
|
41,164
|
102,594
|
59,119
|
-40,097
|
77,377
|
71,012
|
116,044
|
69,997
|
54,738
|
-
|
Net margin
|
8.2%
|
12.48%
|
12.72%
|
9.07%
|
-0.3%
|
6.11%
|
10.71%
|
8.57%
|
9.14%
|
4.87%
|
13.7%
|
8.25%
|
10.83%
|
11.12%
|
-7.43%
|
14.89%
|
13.24%
|
11.77%
|
12.26%
|
9.69%
|
-
|
EPS
2 |
-
|
160.1
|
168.5
|
64.97
|
-2.180
|
42.87
|
85.71
|
128.6
|
76.00
|
42.43
|
113.2
|
75.86
|
189.1
|
108.9
|
-73.89
|
142.6
|
124.7
|
211.9
|
137.2
|
97.71
|
-
|
Dividend per Share
2 |
-
|
50.00
|
50.00
|
-
|
50.00
|
-
|
50.00
|
50.00
|
-
|
50.00
|
-
|
50.00
|
50.00
|
-
|
60.00
|
-
|
60.00
|
-
|
-
|
60.00
|
-
|
Announcement Date
|
14/02/20
|
07/08/20
|
06/08/21
|
12/11/21
|
10/02/22
|
13/05/22
|
29/07/22
|
29/07/22
|
31/10/22
|
14/02/23
|
12/05/23
|
31/07/23
|
31/07/23
|
31/10/23
|
14/02/24
|
30/04/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
147,514
|
175,692
|
275,053
|
277,475
|
374,716
|
496,373
|
634,950
|
774,942
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
105,501
|
110,042
|
117,409
|
130,273
|
72,244
|
345,000
|
228,003
|
204,825
|
ROE (net income / shareholders' equity)
|
7.3%
|
8.2%
|
6.5%
|
6.3%
|
5.3%
|
10.1%
|
9.23%
|
7.61%
|
ROA (Net income/ Total Assets)
|
6.86%
|
7.29%
|
6.01%
|
5.84%
|
4.41%
|
7.46%
|
6.83%
|
6.01%
|
Assets
1 |
1,853,933
|
2,030,821
|
2,088,798
|
2,295,058
|
2,755,321
|
3,412,062
|
3,412,714
|
3,402,774
|
Book Value Per Share
2 |
3,257
|
3,416
|
3,708
|
4,101
|
4,411
|
4,766
|
5,061
|
5,299
|
Cash Flow per Share
2 |
374.0
|
420.0
|
388.0
|
420.0
|
404.0
|
717.0
|
609.0
|
588.0
|
Capex
1 |
87,133
|
122,797
|
111,455
|
139,319
|
210,988
|
125,220
|
107,020
|
111,275
|
Capex / Sales
|
6.24%
|
8.63%
|
7.44%
|
8.02%
|
10.45%
|
5.78%
|
4.97%
|
5.2%
|
Announcement Date
|
14/02/20
|
12/02/21
|
10/02/22
|
14/02/23
|
14/02/24
|
-
|
-
|
-
|
Last Close Price
6,382
JPY Average target price
6,136
JPY Spread / Average Target -3.85% Consensus |
1st Jan change
|
Capi.
|
---|
| +20.67% | 22.59B | | +20.61% | 43.18B | | +14.56% | 14.56B | | +13.94% | 13.54B | | +43.35% | 11.5B | | -8.37% | 6.93B | | -0.05% | 6.79B | | -8.87% | 5.73B | | +10.21% | 5.36B | | -2.27% | 4.81B |
Generic Pharmaceuticals
|